Rare diseases
Investigational molecules
Locations
Back to Poland33 clinical trials in Grodzisk Mazowiecki, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
PolandStudy on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
PolandStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
PolandStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
PolandStudy on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis
PolandStudy on Balcinrenone and Dapagliflozin for Adults with Chronic Kidney Disease and Albuminuria
PolandSafety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome
PolandStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
PolandStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
PolandStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
PolandA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
PolandA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials exploring treatments for atherosclerotic cardiovascular disease and stroke prevention. Studies focus on innovative therapies for heart failure and post-myocardial infarction care.
Researchers are evaluating novel compounds like asundexian and obicetrapib for improving cardiovascular outcomes.
Comprehensive studies investigating treatments for various autoimmune disorders, including psoriatic arthritis and multiple sclerosis. Research focuses on targeted therapies and disease-modifying treatments.
Novel biologics and immunomodulators are being tested to improve patient outcomes.
Innovative research into treatments for chronic obstructive pulmonary disease, examining new therapeutic approaches for managing moderate to severe cases.
Studies evaluate medications like tezepelumab and benralizumab for improving respiratory outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
